Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma
Nathan C. Sheffield, Gaëlle Pierron, Johanna Klughammer, et al.
Nature Medicine (2017) Vol. 23, Iss. 3, pp. 386-395
Open Access | Times Cited: 226

Showing 1-25 of 226 citing articles:

Ewing sarcoma
Thomas G. P. Grünewald, Florencia Cidre‐Aranaz, Didier Surdez, et al.
Nature Reviews Disease Primers (2018) Vol. 4, Iss. 1
Closed Access | Times Cited: 651
Intratumoral heterogeneity in cancer progression and response to immunotherapy
Ilio Vitale, Efrat Shema, Sherene Loi, et al.
Nature Medicine (2021) Vol. 27, Iss. 2, pp. 212-224
Closed Access | Times Cited: 578
Sarcoma classification by DNA methylation profiling
Christian Koelsche, Daniel Schrimpf, Damian Stichel, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 384
RnBeads 2.0: comprehensive analysis of DNA methylation data
Fabian Müller, Michael Scherer, Yassen Assenov, et al.
Genome biology (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 277
The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space
Johanna Klughammer, Barbara Kiesel, Thomas Roetzer-Pejrimovsky, et al.
Nature Medicine (2018) Vol. 24, Iss. 10, pp. 1611-1624
Open Access | Times Cited: 255
Sarcoma treatment in the era of molecular medicine
Thomas G. P. Grünewald, Marta M. Alonso, Sofia Avnet, et al.
EMBO Molecular Medicine (2020) Vol. 12, Iss. 11
Open Access | Times Cited: 245
Ewing’s Sarcoma
Nicolò Riggi, Mario L. Suvà, Ivan Stamenkovic
New England Journal of Medicine (2021) Vol. 384, Iss. 2, pp. 154-164
Open Access | Times Cited: 238
Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients
De‐Chen Lin, Ming‐Rong Wang, H. Phillip Koeffler
Gastroenterology (2017) Vol. 154, Iss. 2, pp. 374-389
Open Access | Times Cited: 219
Ewing Sarcoma—Diagnosis, Treatment, Clinical Challenges and Future Perspectives
Stefan Zöllner, James F. Amatruda, Sebastian Bauer, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 8, pp. 1685-1685
Open Access | Times Cited: 180
The epigenomics of sarcoma
Benjamin A. Nacev, Kevin B. Jones, Andrew M. Intlekofer, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 10, pp. 608-623
Open Access | Times Cited: 172
Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden
Peter Peneder, Adrian M. Stütz, Didier Surdez, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 147
Enhancers in disease: molecular basis and emerging treatment strategies
Annique Claringbould, Judith B. Zaugg
Trends in Molecular Medicine (2021) Vol. 27, Iss. 11, pp. 1060-1073
Open Access | Times Cited: 146
Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options
Jae Young So, Joyce E. Ohm, Stan Lipkowitz, et al.
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108253-108253
Open Access | Times Cited: 137
Heterogeneity of the tumor immune microenvironment and its clinical relevance
Qingzhu Jia, Aoyun Wang, Yixiao Yuan, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 130
Epigenetics, DNA damage, and aging
Carolina Soto-Palma, Laura J. Niedernhofer, Christopher Faulk, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 16
Open Access | Times Cited: 85
Comparative analysis of genome-scale, base-resolution DNA methylation profiles across 580 animal species
Johanna Klughammer, Daria Romanovskaia, Amelie Nemc, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 59
Biology of Bone Sarcomas and New Therapeutic Developments
Hannah K. Brown, Kristina Schiavone, F. Gouin, et al.
Calcified Tissue International (2017) Vol. 102, Iss. 2, pp. 174-195
Open Access | Times Cited: 137
The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma
Ana Banito, Xiang Li, Aimée N. Laporte, et al.
Cancer Cell (2018) Vol. 33, Iss. 3, pp. 527-541.e8
Open Access | Times Cited: 134
Transcriptional Programs Define Intratumoral Heterogeneity of Ewing Sarcoma at Single-Cell Resolution
Marie-Ming Aynaud, Olivier Mirabeau, Nadège Gruel, et al.
Cell Reports (2020) Vol. 30, Iss. 6, pp. 1767-1779.e6
Open Access | Times Cited: 126
Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma
Choh Yeung, Anna E. Gibson, Sameer H. Issaq, et al.
Cancer Research (2019) Vol. 79, Iss. 19, pp. 5060-5073
Open Access | Times Cited: 108
Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification
Anna Wenger, Sandra Ferreyra Vega, Teresia Kling, et al.
Neuro-Oncology (2019) Vol. 21, Iss. 5, pp. 616-627
Open Access | Times Cited: 100
Class I HDAC inhibitors enhance YB ‐1 acetylation and oxidative stress to block sarcoma metastasis
Amal M. El-Naggar, Syam Prakash Somasekharan, Yemin Wang, et al.
EMBO Reports (2019) Vol. 20, Iss. 12
Open Access | Times Cited: 98
Multi-faceted epigenetic dysregulation of gene expression promotes esophageal squamous cell carcinoma
Wei Cao, Hayan Lee, Wei Wu, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 97
EZH2 Inhibition in Ewing Sarcoma Upregulates GD2 Expression for Targeting with Gene-Modified T Cells
Sareetha Kailayangiri, Bianca Altvater, Stefanie Lesch, et al.
Molecular Therapy (2019) Vol. 27, Iss. 5, pp. 933-946
Open Access | Times Cited: 93
The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis
Heinrich Kovar, Lisa Bierbaumer, Branka Radic-Sarikas
Cells (2020) Vol. 9, Iss. 4, pp. 972-972
Open Access | Times Cited: 88
Page 1 - Next Page

Scroll to top